Delivery Order SPE2DB20D2014-SPE2DB25FB82P

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $8.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,982.20, is a delivery order for the supply of the drug ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 22, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,320.24 firm fixed-price delivery order is for the supply of the medication "ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML". The contract has an ultimate completion date of April 11, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,287.74 firm fixed-price delivery order covers the supply of the medication ZEPBOUND 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.00 delivery order contract is for the supply of ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML, a medical product. The contract is a firm fixed-price delivery order with a completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,371.00 firm fixed price delivery order contract is for the supply of ZEPBOUND 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,390.97, is a delivery order for the supply of ZEPBOUND 7.5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of November 6, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,050.32 firm fixed-price delivery order is for 4567491497 ! ZEPBOUND 5 MG/0.5 ML PEN 0.5ML, with a period of performance through March 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,731.23 firm fixed-price delivery order contract is for ZEPBOUND 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,525.16, is a Firm Fixed Price Delivery Order for the supply of the medical product "ZEPBOUND 5 MG/0.5 ML PEN 0.5ML". The contract has an ultimate completion date of March 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,431.76 firm fixed-price delivery order covers the supply of ZEPBOUND 5 MG/0.5 ML PEN 0.5ML medical products. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB82P
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,857.73, is a delivery order for the supply of the medication ZEPBOUND 2.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price, non-set-aside award with a completion date of May 5, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This prime contract, designated as SPE2DX, provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:04 AM